GoodRx Holdings (GDRX) Cash from Financing Activities (2019 - 2026)
GoodRx Holdings (GDRX) reported Cash from Financing Activities of -$16.3 million for Q1 2026, up 84.46% on a YoY basis from -$8.8 million in Q1 2025, and down 27.11% sequentially from -$12.8 million in Q4 2025.
GoodRx Holdings (GDRX) Cash from Financing Activities (2019 - 2026) Analysis & Trends
GoodRx Holdings (GDRX) has 8 years of Cash from Financing Activities data on file, last reported at -$16.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 84.46% year-over-year to -$16.3 million; the trailing twelve-month figure through Mar 2026 stood at -$145.9 million (up 48.17% YoY), and the FY2025 full-year result was -$234.5 million, up 30.53% from the prior year.
- Cash from Financing Activities eased to -$16.3 million in Q1 2026, from -$12.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of -$864000.0 in Q2 2024 to a low of -$172.1 million in Q3 2024.
- A 5-year average of -$51.5 million and a median of -$16.3 million in 2026 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 97.19% in 2024 and plunged 5794.44% in 2025, its largest moves.
- Tracing GDRX's Cash from Financing Activities over 5 years: stood at -$4.8 million in 2022, then plunged by 2524.43% to -$125.6 million in 2023, then jumped by 97.19% to -$3.5 million in 2024, then tumbled by 263.37% to -$12.8 million in 2025, then declined by 27.11% to -$16.3 million in 2026.
- Business Quant data shows GDRX's Cash from Financing Activities at -$16.3 million in Q1 2026, -$12.8 million in Q4 2025, and -$65.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.82 Bn | 24.51 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | -70.02 Mn |
| 3 | Healthequity | 8.33 Bn | 8.07 Bn | 256.31 Mn | -137.18 Mn |
| 4 | Hinge Health | 5.95 Bn | 5.63 Bn | 154.23 Mn | -112.85 Mn |
| 5 | 10x Genomics | 5.83 Bn | 5.29 Bn | 106.18 Mn | -8.42 Mn |
| 6 | MiniMed | 4.55 Bn | 4.25 Bn | 480.00 Mn | 512.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 13.46 Mn |
| 8 | Doximity | 3.95 Bn | 3.20 Bn | 125.97 Mn | -93.16 Mn |
| 9 | Privia Health | 3.15 Bn | 2.73 Bn | - | -10.67 Mn |
| 10 | GoodRx Holdings | 1.02 Bn | 789.29 Mn | 173.85 Mn | -16.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.30 Mn |
| Mar 31, 2026 | -16.30 Mn |
| Dec 31, 2025 | -12.83 Mn |
| Dec 31, 2025 | -12.83 Mn |
| Sep 30, 2025 | -65.81 Mn |
| Sep 30, 2025 | -65.81 Mn |
| Jun 30, 2025 | -50.93 Mn |
| Jun 30, 2025 | -50.93 Mn |
| Mar 31, 2025 | -104.90 Mn |
| Mar 31, 2025 | -104.90 Mn |
| Dec 31, 2024 | -3.53 Mn |
| Dec 31, 2024 | -3.53 Mn |
| Sep 30, 2024 | -172.13 Mn |
| Sep 30, 2024 | -172.13 Mn |
| Jun 30, 2024 | -864,000.00 |
| Jun 30, 2024 | -864,000.00 |
| Mar 31, 2024 | -160.97 Mn |
| Mar 31, 2024 | -160.97 Mn |
| Dec 31, 2023 | -125.61 Mn |
| Dec 31, 2023 | -125.61 Mn |